Phacilitate Leaders World

Conference speakers

Loading
Greg Bonfiglio

Greg Bonfiglio

Founder & Managing Partner, Proteus, LLC

Mr. Bonfiglio is the Founder & Managing Partner of Proteus, LLC – an investment and advisory firm focused solely on Regenerative Medicine.  Formed in 2006, Proteus provides fund management and consulting services to the regenerative medicine industry.   Proteus works with cell & gene therapy companies across all stages of development from early stage entities to large public companies, as well as governmental organizations pursuing RM initiatives.        

Mr. Bonfiglio serves on the Board of Healios KK, one of the largest publicly traded RM companies in Japan.  Mr. Bonfiglio is the Chairman of the Board of the Centre for Commercialization of Regenerative Medicine (RM Translation Center in Toronto, Canada).   He is on the Board of BioBridge Global (RM Translation Center in San Antonio, Texas).   He is on the ISSCR Finance Committee.

Mr. Bonfiglio was an early investor in the RM field, and he continues to be actively involved in the space.  He is a frequent speaker at Regenerative Medicine Conferences.  Mr. Bonfiglio has served on the Boards of several other RM companies, including VistaGen Therapeutics (in vitro tools from hESCs); Advanced Cell Technologies (hESC therapeutics); California Stem Cell (hESC tools & therapeutics); and StemCyte, Inc. (cord blood storage & therapeutics).   

Mr. Bonfiglio has over 35 years’ experience working with technology companies.    From 2000 – 2005, Mr. Bonfiglio was a General Partner with Anthem Venture Partners – an early stage venture fund in California.    While at Anthem, Mr. Bonfiglio led investments in both biotechnology and IT.    

Prior to joining Anthem, he was a Partner with Morrison & Foerster, where he worked extensively with technology clients.   Mr. Bonfiglio was an Adjunct Professor of Law at Stanford Law School, from 1996 to 2000.  He has been a Guest Lecturer at the Stanford Business School on the Commercialization of RM Technologies.  From 1995 -2005, he was a regular Guest Lecturer at the UC Berkley Haas Business School in the Entrepreneurship Program.     

Mr. Bonfiglio received his B.A. in Mathematics (magna cum laude) from Michigan State University in 1975, and his J.D. (magna cum laude) from the University of Michigan Law School in 1981.  

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK